CEP55 and esophageal squamous cell carcinoma: These were used to validate the expression levels of APOC1 and CEP55 and their related miRNAs (hsa-miR-143-5p, hsa-miR-145-3p, hsa-miR-378a-5p, hsa-miR-145-5p, hsa-miR-1468-5p, hsa-miR-3065-5p, hsa-miR-320a-3p, hsa-miR-378a-3p, hsa-miR-504-5p, and hsa-miR-6507-5p) in patients with esophageal squamous cell carcinoma.